New Horizon Health was China’s first cancer-screening device company to go public, and was once the envy of the industry as its revenue surged more than 20 times in the three years through 2023 and its gross margin jumped from 52% to 90%.

FAST NEWS: New Horizon Health CFO, auditor resign

The Latest: Cancer-screening device maker New Horizon Health Ltd. (6606.HK) announced Monday that Deloitte has resigned as its auditor, effective Sept. 9. Separately, the company said its CFO Gao Yu also announced…

CHINA BULLETIN: Mixed Manufacturing Signals

After a rough few weeks, China stocks finally gave investors something to cheer about last week when most of the country was closed for the Oct. 1 National Day holiday. The Hang Seng China Enterprises Index rose 2.7% during the week, while the iShares MSCI China ETF rose by a smaller 1.3%, compared with a 3% rise for the broader Hang Seng Index.